Taurine: A Novel Tumor Marker for Enhanced Detection of Breast Cancer Among Female Patients

Citation:
Agouza, E. I. M., S. S. Eissa, E. M. M. Houseini, and D. E. - N. A. E. E. O. M. Hameed, "Taurine: A Novel Tumor Marker for Enhanced Detection of Breast Cancer Among Female Patients", Angiogenesis, vol. 14, issue 3, pp. 321-330, 2011.

Abstract:

Introduction: The antioxidant Taurine found to display antineoplastic effect through down regulation of angiogenesis and enhancement of tumor cell apoptosis. It has been found that progressive inhibition of apoptosis and induction of angiogenesis may contribute to tumor initiation, growth and metastasis in the pathogenesis of breast cancer. Aim of the study: To correlate taurine level with the levels of some bioomolecules operating in both angiogenesis (VEGF, CD31) and apoptosis (TNF-a and Caspas-3) which could help for breast cancer pronostication and to evaluate a possible role of serum taurine level as an early marker for breast cancer in Egyptian patients. Patients and methods: Four groups of a total 85 female candidates were studied in this work. The first group consists of 50 female patients at National Cancer Institute (NCI), Cairo University were diagnosed and undergoing surgery for breast carcinoma. In the second group 10 having benign breast lesions, were included. The third group consists of five cases, with positive family history. Twenty healthy females were also recruited as control. A preoperative blood sample were taken from each patient to measure serum level of VEGF; Taurine; CA15.3 and TNFa. Sample of fresh tumor and their corresponding safety margins were obtained from the first and second groups, for determination of caspase-3; histopathological examination and immunohistochemical assay of VEGF and CD31.

Notes:

n/a

PreviewAttachmentSize
CU-PDF.pdf607.34 KB